This opportunity is closed.The response deadline was See listing.

HEALTH AND HUMAN SERVICES, DEPARTMENT OF / OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE / BARDA - ASPR / DAAPPO / BARDA DCMA / OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Clinical Development of VE303, a Live Biotherapeutic Product (LBP) for Prevention of Recurrent C. difficile Infection and Treatment of Antibiotic-Induced Dysbiosis

BAA-18-100-SOL-00003ContractAward NoticeSAM.gov

Quick Facts

NAICS

541714

Set-Aside

Full & Open

Place of Performance

Boston, MA

Description

This a competivitely awarded cost share contract. The Government's total cost share is $76,943,067.

Submission Details

Response Deadline: Nov 1, 2019

Details

Type: Contract
Deadline: See listing
Source: SAM.gov
First Seen: Mar 2, 2026